首页> 美国卫生研究院文献>Malaria Journal >Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
【2h】

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso

机译:布基纳法索高度季节性传播地区孕妇的恶性疟原虫分离株的离体抗疟药敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEx vivo assays are usually carried out on parasite isolates collected from patients with uncomplicated Plasmodium falciparum malaria, from which pregnant women are usually excluded as they are often asymptomatic and with relatively low parasite densities. Nevertheless, P. falciparum parasites infecting pregnant women selectively sequester in the placenta and may have a different drug sensitivity profile compared to those infecting other patients. The drug sensitivity profile of P. falciparum isolates from infected pregnant women recruited in a treatment efficacy trial conducted in Burkina Faso was determined in an ex vivo study.
机译:背景离体分析通常在从没有并发症的恶性疟原虫疟疾患者中收集的寄生虫分离物中进行,由于通常无症状且寄生虫密度相对较低,因此通常排除孕妇。然而,恶性疟原虫寄生虫感染孕妇选择性地隔离在胎盘中,与感染其他患者的恶性疟原虫相比可能具有不同的药物敏感性。在离体研究中确定了在布基纳法索进行的治疗功效试验中招募的感染孕妇的恶性疟原虫分离株的药物敏感性分布。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号